Abstract: Provided is a biodegradable laminated structure comprising a substrate and a tie layer, wherein said tie layer is selected from the group consisting of PBSA, PBS, PBAT and a mixture of PCL with PLA and combinations thereof. The laminated structure may comprise two, three, four, five or more layers and may be coated or uncoated.

Abstract: The present invention is directed to biodegradable sheets and straws formed from a composition comprising a first biodegradable polymer selected from the group consisting of PBAT, PBS, PLA and combinations thereof; and a second biodegradable polymer selected from the group consisting of PBS, PLA, PCL, PBSA, PBAT and combinations thereof, wherein the first biodegradable polymer is different from the second biodegradable polymer and wherein the straws or sheets have a thickness of 100-250 microns.

Abstract: The invention relates to a method of operating a zinc-bromine battery, especially at a high temperature, comprising adding 1-n-butyl-2-methyl-pyridinium bromide to the electrolyte of said battery, and charging or discharging said cell. Also provided is the use of 1-n-butyl-2-methyl-pyridinium bromide as an additive in a zinc-bromine battery operating at a temperature above 30° C., and an aqueous concentrate with high content of 1-n-butyl-2-methyl-pyridinium bromide.

Abstract: The invention relates to the use of 1-alkyl-2-alkyl pyridinium halide (e.g., 1-ethyl-2-methyl pyridinium bromide), 1-alkyl-3-alkyl pyridinium halide (e.g., 1-ethyl-3-methyl pyridinium bromide) or 1-alkyl-3-alkyl imidazolium halide (e.g., 1-butyl 3-methyl imidazolium bromide) as additives in an electrolyte used in hydrogen/bromine cells, for complexing the elemental bromine formed in such cells. The invention also provides an electrolyte comprising aqueous hydrogen bromide and said additives, and processes for operating an electrochemical flow cell selected from the group consisting of hydrogen/bromine or vanadium/bromine cells.

Abstract: The invention relates to a method of operating a zinc-bromine battery, especially at a high temperature, comprising adding 1-n-butyl-2-methyl-pyridinium bromide to the electrolyte of said battery, and charging or discharging said cell. Also provided is the use of 1-n-butyl-2-methyl-pyridinium bromide as an additive in a zinc-bromine battery operating at a temperature above 30° C., and an aqueous concentrate with high content of 1-n-butyl-2-methyl-pyridinium bromide.

Abstract: The invention relates to the use of 1-alkyl-2-alkyl pyridinium halide (e.g., 1-ethyl-2-methyl pyridinium bromide), 1-alkyl-3-alkyl pyridinium halide (e.g., 1-ethyl-3-methyl pyridinium bromide) or 1-alkyl-3-alkyl imidazolium halide (e.g., 1-butyl 3-methyl imidazolium bromide) as additives in an electrolyte used in hydrogen/bromine cells, for complexing the elemental bromine formed in such cells. The invention also provides an electrolyte comprising aqueous hydrogen bromide and said additives, and processes for operating an electrochemical flow cell selected from the group consisting of hydrogen/bromine or vanadium/bromine cells.

Abstract: The invention relates to the use of nitrogen-containing compounds belonging to the classes of N-alkyl pyridinium halide, N-alkyl-2-alkyl pyridinium halide and 1-alkyl-3-alkyl imidazolium halide, as additives in electrolyte solutions for zinc bromine membraneless flow cells. The invention also provides electrolyte solutions comprising such additives and processes for operating said cells.

Abstract: The invention relates to the use of at least one 1-alkyl-3-alkyl-pyridinium halide, in particular 1-alkyl-3-methyl-pyridinium bromide, as an additive in bromine-generating electrochemical cells, such as zinc/bromine cells. Processes for preparing 1-alkyl-3-methyl-pyridinium bromide and concentrated aqueous solutions comprising same for use as additives in the aforementioned cells, are also disclosed.

Abstract: The invention relates to the use of at least one 1-alkyl-3-alkyl-pyridinium halide, in particular 1-alkyl-3-methyl-pyridinium bromide, as an additive in bromine-generating electrochemical cells, such as zinc/bromine cells. Processes for preparing 1-alkyl-3-methyl-pyridinium bromide and concentrated aqueous solutions comprising same for use as additives in the aforementioned cells, are also disclosed.

Abstract: The invention relates to the use of nitrogen-containing compounds belonging to the classes of N-alkyl pyridinium halide, N-alkyl-2-alkyl pyridinium halide and 1-alkyl-3-alkyl imidazolium halide, as additives in electrolyte solutions for zinc bromine membraneless flow cells. The invention also provides electrolyte solutions comprising such additives and processes for operating said cells.

Abstract: This invention generally relates to electrochemical cells utilizing magnesium anodes, new solutions and intercalation cathodes. The present invention is a new rechargeable magnesium battery based on magnesium metal as an anode material, a modified Chevrel phase as an intercalation cathode for magnesium ions and new electrolyte solution from which magnesium can be deposited reversibly, which have a very wide electrochemical window. The Chevrel phase compound is represented by the formula Mo6S8-YSeY in which y is higher than 0 and lower than 2 or by the formula MXMo6S8 in which M is selected from the group comprising of copper (Cu), nickel (Ni), silver (Ag) and/or any other transition metal; further wherein x is higher than 0 and lower than 2.

Abstract: The invention relates to the use of 1-alkyl-2-alkyl pyridinium halide (e.g., 1-ethyl-2-methyl pyridinium bromide), 1-alkyl-3-alkyl pyridinium halide (e.g., 1-ethyl-3-methyl pyridinium bromide) or 1-alkyl-3-alkyl imidazolium halide (e.g., 1-butyl 3-methyl imidazolium bromide) as additives in an electrolyte used in hydrogen/bromine cells, for complexing the elemental bromine formed in such cells. The invention also provides an electrolyte comprising aqueous hydrogen bromide and said additives, and processes for operating an electrochemical flow cell selected from the group consisting of hydrogen/bromine or vanadium/bromine cells.

Abstract: Disclosed are lithium-ion secondary electrochemical cells and methods of making lithium-ion secondary electrochemical cells.

Abstract: Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical compositions thereof.

Abstract: The present invention provides crystalline and amorphous salts of O-desmethylvenlafaxine and processes for preparing said salts of O-desmethylvenlafaxine. The present invention further provides pharmaceutical compositions comprising said salts of O-desmethylvenlafaxine.

Abstract: The present invention provides 3-benzyloxy-2-aminopyridine (BOPA), 3-(2-Hydroxyethyl)-2-methyl-9-hydoxy-4H-pyrido[1,2-a]pyrimidine-4-one (HMBP), 3-(2-Chloroethyl)-2-methyl-9-hydoxy-4H-pyrido[1,2-a]pyrimidine-4-one (CMHP) and 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrrido[1,2-a]-pyrimidin-4-one (CMHTP) useful as intermediates for the preparation of paliperidone. The present invention also provides processes for preparing these intermediates and for preparing paliperidone.

Abstract: A Sitagliptin phosphate characterized by data selected from the group consisting of: a powder XRD pattern with peaks at 4.7, 13.5, 17.7, 18.3, and 23.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 4.7, 13.5, and 15.5±0.2 degrees two theta and at least another two peaks selected from the following list: 14.0, 14.4, 18.3, 19.2, 19.5 and 23.7±0.2 degrees two theta; and a powder XRD pattern with peaks at about 13.5, 19.2, and 19.5±0.2 degrees two theta and at least another two peaks selected from the following list: 4.7, 14.0, 15.1, 15.5, 18.3, and 18.7±0.2 degrees two theta; a powder XRD pattern with peaks at about 13.5, 15.5, 19.2, 23.7, and 24.4±0.2 degrees two theta; and a powder XRD pattern with peaks at about 4.65, 13.46, 17.63, 18.30, and 23.66±0.10 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided.

Abstract: The present invention is related to processes for the preparation of paliperidone crystalline Form II. The invention also provides a paliperidone crystalline Form II containing isopropyl alcohol, and processes for preparing the same.

Abstract: An amorphous form of Retapamulin, preferably in powder form, and processes for preparation thereof, are provided. Amorphous Retapamulin of the present invention can contain less than about 10 percent crystallinity, preferably less than about 5 percent crystallinity. Pharmaceutical compositions comprising amorphous Retapamulin are also provided.

Abstract: A Sitagliptin crystalline form characterized by PXRD pattern having any 5 peaks selected from the group consisting of 7.4, 11.5, 16.7, 17.7, 18.9, 24.1, 24.5, 27.0, 28.5 and 28.8±0.2 degrees 2-theta, wherein any combination of peaks selected includes the peak at 7.4±0.2 degrees two theta, processes for preparing said Sitagliptin crystalline form, and pharmaceutical compositions thereof, are provided.